Docoh
Loading...

CALT Calliditas Therapeutics AB

70 filings

Newest first
Filter options loading...
Top filers
Top filing types
Recent filing years
6-K
CALT Calliditas Therapeutics AB
18 Nov 21
Current report (foreign)
5:13pm
6-K
CALT Calliditas Therapeutics AB
2 Nov 21
Calliditas Therapeutics’ nomination committee for the AGM 2022
9:25am
6-K
CALT Calliditas Therapeutics AB
16 Sep 21
Current report (foreign)
4:27pm
6-K
CALT Calliditas Therapeutics AB
14 Sep 21
Current report (foreign)
5:05pm
6-K
CALT Calliditas Therapeutics AB
31 Aug 21
Current report (foreign)
9:12am
6-K
2021 Q2
CALT Calliditas Therapeutics AB
20 Aug 21
Current report (foreign)
5:28pm
6-K
CALT Calliditas Therapeutics AB
13 Aug 21
Calliditas Therapeutics has resolved on a directed share issue in the amount of 2.4 million shares, raising proceeds of approximately SEK 324 million
8:22am
6-K
CALT Calliditas Therapeutics AB
12 Aug 21
Current report (foreign)
8:00pm
424B5
CALT Calliditas Therapeutics AB
12 Aug 21
Prospectus supplement for primary offering
5:10pm
6-K
CALT Calliditas Therapeutics AB
9 Aug 21
Calliditas Receives FDA Fast Track Designation for setanaxib in PBC
9:15am
6-K
CALT Calliditas Therapeutics AB
23 Jul 21
Calliditas Therapeutics and STADA partner to register and commercialize specialty therapy for IgA Nephropathy in Europe
4:03pm
6-K
CALT Calliditas Therapeutics AB
19 Jul 21
Calliditas secures $75 million term loan facility
7:20am
F-3ASR
CALT Calliditas Therapeutics AB
12 Jul 21
Automatic shelf registration (foreign)
5:10pm
6-K
CALT Calliditas Therapeutics AB
28 May 21
Calliditas Announces Submission of Marketing Authorisation Application for Nefecon to the European Medicines Agency
4:05pm
6-K
CALT Calliditas Therapeutics AB
27 May 21
Adoption of income statement and balance sheet for the financial year 2020 and discharge from liability
4:09pm
6-K
CALT Calliditas Therapeutics AB
18 May 21
Filing of New Drug Application submission to the FDA
9:00am
6-K
CALT Calliditas Therapeutics AB
28 Apr 21
FDA grants priority review for Nefecon, for patients with IgA nephropathy
9:12am
20-F
2020 FY
CALT Calliditas Therapeutics AB
27 Apr 21
Annual report (foreign)
5:16pm
6-K
2020 FY
CALT Calliditas Therapeutics AB
26 Apr 21
Current report (foreign)
8:00pm
6-K
CALT Calliditas Therapeutics AB
26 Apr 21
Current report (foreign)
4:30pm